The role of cholecalciferol deficiency in the pathogenesis of polycystic ovary syndrome of patients with polycystic
ovary syndrome, including vitamin 25(OH)D3 level. Methods: In total, 81 patients
CLINICAL AND ANAMNESTIC MARKERS OF INFERTILE PATIENTS WITH BENIGN NEOPLASMS OF THE UTERUS AND OVARIES and
ovaries. Materials and methods. The study involved 498 infertile patients with benign tumors of the uterus
"Ringed by fate". Carcinogenic risks in patients with polycystic ovary syndromePolycystic
ovary syndrome is a proven risk factor for both endometrial hyperplasia and cancer
Melatonin receptors and serotonin: age-related changes in the ovaries receptors, as well as serotonin synthesis in the
ovaries during ontogenesis
The level of vitamin D in women with polycystic ovary syndrome, that the level of vitamin D deficiency is more pronounced in patients with Polycystic
Ovary Syndrome compared
The Use of Myoand D-Hiro Inositol in the Treatment of Polycystic OvarySyndromeThe Use of Myoand D-Hiro Inositol in the Treatment of Polycystic
OvarySyndrome
Polycystic ovary syndrome and obesity: a modern paradigmPolycystic
ovary syndrome is a heterogeneous endocrine disease that affects women of childbearing